Suchergebnisse - "Barlesi, F"

PubPharm (258)

91

Ipilimumab and metastatic lung cancer : Can we change the natural history of the disease?

enthalten in: Revue des maladies respiratoires | 2015

von Boyer, A. | Greillier, L. | Barazzutti, H. | +2

92

Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients : results of an open-label, randomized, controlled phase II study (CERTO)

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2015

von Vansteenkiste, J. | Barlesi, F. | Waller, C. | +16

93

Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer : results from the IFCT-0802 trial†

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2015

von Pujol, J. | Lavole, A. | Quoix, E. | +50

CommentIn: Ann Oncol. 2015 Sep;26(9):2003. - PMID 26113649

94

Multicystic kidney disease : a complication of crizotinib

enthalten in: Diagnostic and interventional imaging | 2015

von Souteyrand, P. | Burtey, S. | Barlesi, F.

95

Randomized, phase III trial of figitumumab in combination with erlotinib versus erlotinib alone in patients with nonadenocarcinoma nonsmall-cell lung cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2015

von Scagliotti, G. | Bondarenko, I. | Blackhall, F. | +12

CommentIn: Ann Oncol. 2015 Mar;26(3):447-8. - PMID 25524479

96

Global brain metastases management strategy : a multidisciplinary-based approach

enthalten in: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique | 2015

von Métellus, P. | Tallet, A. | Dhermain, F. | +8

97

Systemic treatment of brain metastases from lung cancer

enthalten in: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique | 2015

von Barlesi, F. | Spano, J. | Cortot, A. | +3

98

Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO)

enthalten in: Annals of oncology | 2015

von Vansteenkiste, J. | Barlesi, F. | Waller, C. | +16

99

Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial

enthalten in: Annals of oncology | 2015

von Pujol, J. | Lavole, A. | Quoix, E. | +19

100

138TiP CERITINIB IN PATIENTS (PTS) WITH ANAPLASTIC LYMPHOMA KINASE (ALK)-REARRANGED (ALK+) NON-SMALL CELL LUNG CANCER (NSCLC) METASTATIC TO THE BRAIN AND/OR LEPTOMENINGES: THE PHASE II ASCEND-7 STUDY

enthalten in: Annals of oncology | 2015

von Chow, L. | Barlesi, F. | Bertino, E. | +7